Statistics presented in Parliament by the Union Health Minister have once again shown a steady rise in cancer deaths across Goa. Between 2021 and 2025, the State recorded 4,762 cancer-related deaths—an average of nearly 80 lives lost every month—while more than 8,600 new cases were diagnosed during the same period. Annual fatalities climbed from 901 in 2021 to 994 in 2025, an increase of almost 10 per cent in just five years. That this upward trend continues despite the government's expanding healthcare initiatives raises a crucial question: Why are more people dying even as cancer care receives greater policy attention and investment?
The answer lies beyond the State healthcare. Recent cancer registry data shows that the disease is taking its greatest toll on an ageing population, with more than half of all reported cases occurring among people between the ages of 60 and 80. At the same time, indications are that changing lifestyles, dietary habits and other risk factors significantly contribute to the rise in breast, colorectal and oral cancer cases. These challenges are mirrored across the country, but Goa's demographic profile, marked by a relatively older population and greater urbanisation, makes the burden even more distinctive.
While the figures paint a grim picture, the Health Department has taken several forward-looking initiatives that deserve recognition. Its partnership with the Tata Memorial Centre to establish a modern oncology facility by 2027 is expected to spare patients the financial and emotional strain of travelling outside Goa for specialised treatment. Decentralised measures, including day-care chemotherapy units at the South Goa District Hospital, free targeted biologic therapies at Goa Medical College, AI-assisted lung cancer screening and the Cancer Screening Abhiyaan, are welcome initiatives. Goa's pioneering drug pricing policy seeks to make advanced cancer treatment more affordable. At the same time, its Palliative Care Policy acknowledges the importance of preserving dignity and quality of life for patients with advanced disease.
Yet, despite these encouraging steps, the gap between policy and outcomes is evident. The biggest challenge continues to be late diagnosis. Screening camps, mobile units and awareness drives are valuable, but they cannot deliver meaningful results unless cancer screening becomes a routine part of primary healthcare rather than an occasional exercise. Far too many patients still seek medical attention only after the disease has progressed to an advanced stage, when treatment options become fewer, and survival rates decline sharply.
Addressing this problem requires a more focused strategy. Primary Health Centres and Health and Wellness Centres should be equipped and mandated to carry out regular screening for high-risk groups instead of relying largely on periodic camps. Early detection must also be matched by swift action. Fast-track referral systems linking screening centres directly with oncology specialists at Goa Medical College can reduce the delays that often prove costly.
Public awareness campaigns need to move beyond broad messaging and engage communities in recognising early warning signs, dispelling myths and encouraging timely medical consultation. At the same time, cancer registries should be strengthened across both public and private healthcare facilities to generate more detailed data, helping identify environmental, occupational and lifestyle risks unique to different parts of the State. If the State is serious about tackling cancer deaths, its priorities must shift decisively towards prevention, early diagnosis and prompt treatment. We need to bridge the gap between screening and timely clinical intervention.
